Reversal of hepatic steatosis in rats by addition of glucagon to total parenteral nutrition (TPN)
- PMID: 2499733
- DOI: 10.1016/0022-4804(89)90020-6
Reversal of hepatic steatosis in rats by addition of glucagon to total parenteral nutrition (TPN)
Abstract
Infusion of total parenteral nutrition (TPN) with excess carbohydrate calories leads to hepatic steatosis in rats that is associated with an elevated portal insulin/glucagon molar ratio. Previously we have shown that adding glucagon to TPN prevents hepatic steatosis in rats. In this study we attempted to reverse the steatosis by adding glucagon to TPN after 1 week of TPN alone. Adult rats (n = 28) received internal jugular catheters: Group 1 (n = 7), saline (3 cc/h) and chow ad libitum; Group 2 (n = 7), 25% dextrose base TPN solution for 1 week; Group 3 (n = 7), 25% dextrose base TPN for 2 weeks; Group 4 (n = 7), 25% dextrose base TPN for 1 week and then glucagon (15 micrograms/100 g/day) added to TPN for the second week. The infusion rate of TPN was 1.2 ml/100 g/hr (40% kcal greater than control). At 7 days (Group 2) and 14 days (Groups 1, 3, and 4) portal and peripheral venous blood levels were drawn for insulin and glucagon radioimmunoassay, blood glucose determination, and liver function tests; livers were removed for histology and lipid content determination. Blood glucose was equivalent among all groups. Liver function tests were within normal limits. Panlobular vacuolization of the hepatocytes was noted on histology in Groups 2 and 3. Hepatic lipid content was significantly elevated in Group 3. The portal insulin/glucagon molar ratio was increased because of excessive portal venous insulin in Groups 2 and 3 (P less than 0.05 by ANOVA). In contrast, portal venous insulin and the insulin/glucagon molar ratio did not increase in Group 4 and hepatic lipid infiltration was absent when glucagon was added to the TPN solution after 1 week of TPN solution alone. The results suggest that the addition of glucagon to hypertonic dextrose TPN is not only protective in preventing hepatic steatosis, but may reverse steatosis, possibly by increasing hepatic lipid export.
Similar articles
-
Controversies in the Mechanism of Total Parenteral Nutrition Induced Pathology.Children (Basel). 2015 Jul 31;2(3):358-70. doi: 10.3390/children2030358. Children (Basel). 2015. PMID: 27417369 Free PMC article. Review.
-
Addition of L-glutamine to total parenteral nutrition and its effects on portal insulin and glucagon and the development of hepatic steatosis in rats.J Surg Res. 1990 May;48(5):421-6. doi: 10.1016/0022-4804(90)90006-n. J Surg Res. 1990. PMID: 2112667
-
Addition of lipid to total parenteral nutrition prevents hepatic steatosis in rats by lowering the portal venous insulin/glucagon ratio.JPEN J Parenter Enteral Nutr. 1992 Mar-Apr;16(2):106-9. doi: 10.1177/0148607192016002106. JPEN J Parenter Enteral Nutr. 1992. PMID: 1556803
-
Addition of glucagon to total parenteral nutrition (TPN) prevents hepatic steatosis in rats.Surgery. 1988 Aug;104(2):350-7. Surgery. 1988. PMID: 3135627
-
Pathogenesis of hepatic steatosis during total parenteral nutrition.Surg Annu. 1991;23 Pt 2:1-11. Surg Annu. 1991. PMID: 1907028 Review.
Cited by
-
Controversies in the Mechanism of Total Parenteral Nutrition Induced Pathology.Children (Basel). 2015 Jul 31;2(3):358-70. doi: 10.3390/children2030358. Children (Basel). 2015. PMID: 27417369 Free PMC article. Review.
-
An effective protocol for pharmacological defatting of primary human hepatocytes which is non-toxic to cholangiocytes or intrahepatic endothelial cells.PLoS One. 2018 Jul 25;13(7):e0201419. doi: 10.1371/journal.pone.0201419. eCollection 2018. PLoS One. 2018. PMID: 30044872 Free PMC article.
-
The use of fish oil lipid emulsion in the treatment of intestinal failure associated liver disease (IFALD).Nutrients. 2012 Nov 27;4(12):1828-50. doi: 10.3390/nu4121828. Nutrients. 2012. PMID: 23363993 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Research Materials